IOVANCE BIOTHERAPEUTICS, INC. Income Tax Expense
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Income Tax Expense of -$1.37 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-06-30 was -$1.37M, a 169.06% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2026-03-31 was -$665.00K.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-12-31 was $184.00K, a 88.19% decline year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for the quarter ending 2025-09-30 was -$2.40M.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for fiscal 2025 was -$2.07M.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for fiscal 2024 was -$2.83M.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for fiscal 2023 was -$3.48M.
- IOVANCE BIOTHERAPEUTICS, INC. income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.37M 10-Q · filed 2026-08-06 | -$2.04M 10-Q · filed 2026-08-06 | -$1.85M derived: sum of 3 quarters · filed 2026-08-06 | -$4.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$665.00K 10-Q · filed 2026-05-07 | -$481.00K derived: sum of 2 quarters · filed 2026-05-07 | -$2.89M derived: sum of 3 quarters · filed 2026-05-07 | -$898.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $184.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$2.22M derived: sum of 2 quarters · filed 2026-02-24 | -$233.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.07M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$2.40M 10-Q · filed 2025-11-06 | -$417.00K derived: sum of 2 quarters · filed 2026-08-06 | -$2.25M 10-Q · filed 2025-11-06 | -$697.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.99M 10-Q · filed 2026-08-06 | $150.00K 10-Q · filed 2026-08-06 | $1.71M derived: sum of 3 quarters · filed 2026-08-06 | $188.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$1.84M 10-Q · filed 2026-05-07 | -$280.00K derived: sum of 2 quarters · filed 2026-05-07 | -$1.80M derived: sum of 3 quarters · filed 2026-05-07 | -$3.26M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $38.00K derived: sum of 2 quarters · filed 2026-02-24 | -$1.42M derived: sum of 3 quarters · filed 2026-02-24 | -$2.83M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.52M 10-Q · filed 2025-11-06 | -$2.98M derived: sum of 2 quarters · filed 2025-11-06 | -$4.39M 10-Q · filed 2025-11-06 | -$6.14M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | -$1.46M 10-Q · filed 2025-08-07 | -$2.87M 10-Q · filed 2025-08-07 | -$4.63M derived: sum of 3 quarters · filed 2026-02-24 | -$5.87M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | -$1.41M 10-Q · filed 2025-05-08 | -$3.17M derived: sum of 2 quarters · filed 2026-02-24 | -$4.41M derived: sum of 3 quarters · filed 2026-02-24 | -$4.89M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$3.00M derived: sum of 2 quarters · filed 2026-02-24 | -$3.48M derived: sum of 3 quarters · filed 2026-02-24 | -$3.48M 10-K · filed 2026-02-24 |
| 2023-09-30 | -$1.24M 10-Q · filed 2024-11-07 | -$1.72M derived: sum of 2 quarters · filed 2024-11-07 | -$1.72M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$477.00K 10-Q · filed 2024-08-08 | -$477.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2020-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-02-25 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-12 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |